Synergistic protective effects of melatonin and ascorbic acid against benzene-induced genotoxicity, oxidative stress, and activin A/follistatin dysregulation in a rat model of pre-leukemia
The Journal of Toxicological Sciences · 2026 · 51 (8) · 449-461
DOI: 10.2131/jts.51.449 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Toxicological Sciences, 2026. Verfasst von Mohammed M Hussein M Raouf und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science and Health, Koya University. Hauptthemen laut MEDLINE: Melatonin, Ascorbic Acid, Oxidative Stress, Activins. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Science and Health, Koya University.
- Department of Biology, College of Science, Salahaddin University-Erbil.
Zitieren
APA
Raouf, M. M. H. M., Maulood, I. M., & Marzani, Z. S. (2026). Synergistic protective effects of melatonin and ascorbic acid against benzene-induced genotoxicity, oxidative stress, and activin A/follistatin dysregulation in a rat model of pre-leukemia. The Journal of Toxicological Sciences, 51(8), 449-461. https://doi.org/10.2131/jts.51.449
Vancouver
Raouf MMHM, Maulood IM, Marzani ZS. Synergistic protective effects of melatonin and ascorbic acid against benzene-induced genotoxicity, oxidative stress, and activin A/follistatin dysregulation in a rat model of pre-leukemia. The Journal of Toxicological Sciences. 2026;51(8):449-461. doi:10.2131/jts.51.449
BibTeX
@article{Raouf2026,
author = {Raouf, Mohammed M Hussein M and Maulood, Ismail M and Marzani, Zrar Saleem},
title = {Synergistic protective effects of melatonin and ascorbic acid against benzene-induced genotoxicity, oxidative stress, and activin A/follistatin dysregulation in a rat model of pre-leukemia},
journal = {The Journal of Toxicological Sciences},
year = {2026},
volume = {51},
number = {8},
pages = {449--461},
doi = {10.2131/jts.51.449}
}
EUVIMED